Janus Henderson Group PLC Dyne Therapeutics, Inc. Put Options Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
216Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Ra Capital Management, L.P. Boston, MA9.71MShares$112 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$106 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$85.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$85.5 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P75.46MShares$63.2 Million13.81% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $599M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...